XML 17 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Total revenue, net $ 142,038 $ 156,499 $ 438,696 $ 446,809
Less: Cost of goods sold 30,211 33,071 90,692 96,676
Gross margin 111,827 123,428 348,004 350,133
Operating expenses:        
Selling, general and administrative 102,965 120,164 315,966 346,496
Research and development 7,820 10,204 23,554 30,450
Restructuring 14,115   14,115  
Total operating expenses 124,900 130,368 353,635 376,946
Operating loss (13,073) (6,940) (5,631) (26,813)
Interest income, net 163 549 919 1,908
Other (expense) income, net (57) 33 (390) 50
Loss from operations before taxes (12,967) (6,358) (5,102) (24,855)
Income tax (provision) benefit (184) (430) (1,867) 1,929
Net loss $ (13,151) $ (6,788) $ (6,969) $ (22,926)
Loss per share:        
Basic $ (0.03) $ (0.02) $ (0.02) $ (0.06)
Diluted $ (0.03) $ (0.02) $ (0.02) $ (0.06)
Weighted average shares:        
Basic 396,618 389,699 395,681 378,770
Diluted 396,618 389,699 395,681 378,770
Product Revenue, Net        
Total revenue, net $ 141,442 $ 155,190 $ 436,598 $ 441,118
Licensing and Royalty Revenue        
Total revenue, net $ 596 $ 1,309 $ 2,098 $ 5,691